Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.

De Marco D, Clementi N, Mancini N, Solforosi L, Moreno GJ, Sun X, Tumpey TM, Gubareva LV, Mishin V, Clementi M, Burioni R.

PLoS One. 2012;7(4):e34415. doi: 10.1371/journal.pone.0034415. Epub 2012 Apr 4.

2.

One step closer to universal influenza epitopes.

Li OT, Poon LL.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):687-90. doi: 10.1586/eri.09.48. Review.

PMID:
19681695
3.

The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.

Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S.

Mol Immunol. 2013 Dec;56(4):705-19. doi: 10.1016/j.molimm.2013.07.010. Epub 2013 Aug 7. Review.

PMID:
23933511
4.

Broadly neutralizing antibodies against influenza viruses.

Laursen NS, Wilson IA.

Antiviral Res. 2013 Jun;98(3):476-83. doi: 10.1016/j.antiviral.2013.03.021. Epub 2013 Apr 9. Review.

5.

Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Clementi N, Criscuolo E, Castelli M, Mancini N, Clementi M, Burioni R.

Viruses. 2012 Nov 14;4(11):3090-108. doi: 10.3390/v4113090. Review.

6.

HA2 glycopolypeptide of influenza A virus and antiviral immunity.

Varečková E, Mucha V, Kostolanský F.

Acta Virol. 2013;57(2):247-56. Review.

PMID:
23600881
7.

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

Martinez O, Tsibane T, Basler CF.

Int Rev Immunol. 2009;28(1):69-92. doi: 10.1080/08830180802593540. Review.

PMID:
19241254
8.

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

Krammer F, Palese P, Steel J.

Curr Top Microbiol Immunol. 2015;386:301-21. doi: 10.1007/82_2014_408. Review.

PMID:
25007847
9.

Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development.

Khanna M, Sharma S, Kumar B, Rajput R.

Biomed Res Int. 2014;2014:546274. doi: 10.1155/2014/546274. Epub 2014 May 25. Review.

10.

Immune responses to infection with H5N1 influenza virus.

Rimmelzwaan GF, Katz JM.

Virus Res. 2013 Dec 5;178(1):44-52. doi: 10.1016/j.virusres.2013.05.011. Epub 2013 Jun 2. Review.

PMID:
23735534
11.

Prospects of HA-based universal influenza vaccine.

Hashem AM.

Biomed Res Int. 2015;2015:414637. doi: 10.1155/2015/414637. Epub 2015 Feb 15. Review.

12.

Committing the Oldest Sins in the Newest Kind of Ways-Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head.

Krause JC, Crowe JE Jr.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.AID-0021-2014. Review.

PMID:
26104373
13.

Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies.

Lee PS, Wilson IA.

Curr Top Microbiol Immunol. 2015;386:323-41. doi: 10.1007/82_2014_413. Review.

14.

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Jiang S, Li R, Du L, Liu S.

Protein Cell. 2010 Apr;1(4):342-54. doi: 10.1007/s13238-010-0054-6. Epub 2010 May 8. Review.

15.

Broadly neutralizing antiviral antibodies.

Corti D, Lanzavecchia A.

Annu Rev Immunol. 2013;31:705-42. doi: 10.1146/annurev-immunol-032712-095916. Epub 2013 Jan 16. Review.

PMID:
23330954
16.

Antibodies against viruses: passive and active immunization.

Law M, Hangartner L.

Curr Opin Immunol. 2008 Aug;20(4):486-92. doi: 10.1016/j.coi.2008.06.005. Epub 2008 Jul 1. Review.

17.

Antibody-Based Strategies to Prevent and Treat Influenza.

Shriver Z, Trevejo JM, Sasisekharan R.

Front Immunol. 2015 Jul 13;6:315. doi: 10.3389/fimmu.2015.00315. eCollection 2015. Review.

Items per page

Supplemental Content

Write to the Help Desk